RVMD

NASDAQ · Biotechnology

Revolution Medicines Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$94.29

-1.23 (-1.29%)

As of Mar 25, 9:40 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 26 96%

Hold 1 4%

Sell 0 0%

Price Target

Analyst Price Target +21.0% upside

Low Target $80.83

Average Target $114.11

High Target $120.13

Current Price $94.29

Current
$94.29

Target
$114.11

$80.83 $114.11 avg $120.13

Scenario Analysis

Bear Case

$80.83

-14.3%

Low target

Base Case

$114.11

+21.0%

Avg target

Bull Case

$120.13

+27.4%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$124.49

-24.3% from high

52-Week Low

$29.17

+223.2% from low

50-Day SMA

$94.85

-0.6% vs SMA

200-Day SMA

$58.23

+61.9% vs SMA

RSI (14)

62.5

Neutral

Target vs 52W High

$114.11

-8.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%